InChI=1S/C26H33NO9/c1- 12(7- 8- 16(28) 19- 18(30) 11- 27- 23(19) 31) 9- 13(2) 21- 14(3) 22- 17(29) 10- 25(5) 26(35- 21,36- 22) 20(15(4) 34- 25) 24(32) 33- 6/h7- 9,13- 15,20- 22,28H,10- 11H2,1- 6H3,(H,27,31) /b8- 7+,12- 9+,19- 16+/t13- ,14- ,15- ,20- ,21- ,22+,25+,26+/m1/s1 |
DTURANKMSHIDDI-GMYASLLUSA-N |
[C@] 12([C@@H] ([C@] (O[C@] 3(O1) [C@H] ([C@H] (O[C@] 3(CC2=O) C) C) C(=O) OC) ([C@H] (C) /C=C(\C) /C=C/C(=C/4\C(NCC4=O) =O) /O) [H] ) C) [H]![](images/invisible_space.gif) |
|
antibacterial agent
A substance (or active part thereof) that kills or slows the growth of bacteria.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
|
|
View more via ChEBI Ontology
methyl (2R,3S,3aS,5R,6R,7S,9aS)- 5- [(2R,3E,5E,7E)- 7- (2,4- dioxopyrrolidin- 3- ylidene)- 7- hydroxy- 4- methylhepta- 3,5- dien- 2- yl]- 2,6,9a- trimethyl- 8- oxooctahydro- 3a,7- epoxyfuro[3,2- b]oxocine- 3- carboxylate
|
(−)-nocamycin I
|
ChEBI
|
Antibiotic BU 2313B
|
ChEBI
|
BU 2313B
|
ChEBI
|
Bu-2313B
|
ChEBI
|
methyl (1S,2S,3R,5S,8S,9R,10R)- 10- [(2R,3E,5E,7E)- 7- (2,4- dioxopyrrolidin- 3- ylidene)- 7- hydroxy- 4- methylhepta- 3,5- dien- 2- yl]- 3,5,9- trimethyl- 7- oxo- 4,11,12- trioxatricyclo[6.3.1.01,5]dodecane- 2- carboxylate
|
IUPAC
|
28818448
|
PubMed citation
|
Europe PMC
|
6920296
|
PubMed citation
|
Europe PMC
|
|